PRICE T ROWE ASSOCIATES INC /MD/ - REPLIMUNE GROUP INC ownership

REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 100 filers reported holding REPLIMUNE GROUP INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PRICE T ROWE ASSOCIATES INC /MD/ ownership history of REPLIMUNE GROUP INC
ValueSharesWeighting
Q3 2023$99,122
-25.5%
5,793,199
+1.0%
0.02%
-21.1%
Q2 2023$133,121
+37.2%
5,733,012
+4.3%
0.02%
+26.7%
Q1 2023$97,054
-29.5%
5,495,616
+8.5%
0.02%
-31.8%
Q4 2022$137,761
-99.8%
5,064,744
+21.4%
0.02%
+83.3%
Q3 2022$72,037,000
-29.9%
4,171,171
-29.1%
0.01%
-7.7%
Q2 2022$102,827,000
+0.5%
5,882,531
-2.3%
0.01%
+30.0%
Q1 2022$102,266,000
-35.7%
6,022,760
+2.6%
0.01%
-28.6%
Q4 2021$159,040,000
-6.1%
5,868,638
+2.7%
0.01%
-12.5%
Q3 2021$169,453,000
-13.0%
5,717,040
+12.8%
0.02%
-11.1%
Q2 2021$194,768,000
+107.4%
5,069,450
+64.7%
0.02%
+100.0%
Q1 2021$93,917,000
-6.2%
3,078,242
+17.2%
0.01%
-10.0%
Q4 2020$100,170,000
+921.1%
2,625,691
+516.1%
0.01%
+900.0%
Q3 2020$9,810,000
+1.9%
426,161
+10.0%
0.00%0.0%
Q2 2020$9,625,000
+2689.9%
387,339
+1606.9%
0.00%
Q1 2019$345,00022,6930.00%
Other shareholders
REPLIMUNE GROUP INC shareholders Q3 2021
NameSharesValueWeighting ↓
Omega Fund Management, LLC 3,001,319$51,352,56847.17%
Atlas Venture Life Science Advisors, LLC 2,098,300$35,901,9135.56%
Redmile Group, LLC 4,163,922$71,244,7053.39%
Nan Fung Group Holdings Ltd 184,739$3,160,8842.56%
GREAT POINT PARTNERS LLC 638,495$10,924,6491.99%
ACUTA CAPITAL PARTNERS, LLC 150,000$2,566,5001.72%
Ghost Tree Capital, LLC 250,000$4,277,5001.41%
Altium Capital Management LP 155,000$2,652,0501.38%
ACUTA CAPITAL PARTNERS, LLC 1,000$1,766,0001.18%
Camber Capital Management LP 2,000,000$34,2201.13%
View complete list of REPLIMUNE GROUP INC shareholders